Alpha-Fold 3: Revolutionizing Drug Design, Protein Stability, Allostery, and Ai-Driven Therapeutics

AlphaFold, an AI-driven protein structure prediction system developed by DeepMind, has revolutionized structural biology by achieving remarkable accuracy in protein modeling. By leveraging deep learning techniques, AlphaFold provides high-resolution three-dimensional protein structures, surpassing traditional experimental methods in speed and efficiency. Its applications span drug discovery, cancer research, genomics, and bioengineering, aiding in mutation impact analysis, molecular simulations, and personalized medicine. Despite its success, AlphaFold faces challenges in modeling intrinsically disordered proteins, predicting allosteric mechanisms, and simulating protein dynamics. Future advancements in AI-driven structural biology, molecular modeling, and open-source collaboration will further expand its impact in biomedical research and therapeutic innovations. This study explores the methodologies, applications, and future prospects of AlphaFold, highlighting its transformative role in computational biology.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-29
DOI
https://doi.org/10.5281/zenodo.15104810
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alpha-Fold 3: Revolutionizing Drug Design, Protein Stability, Allostery, and Ai-Driven Therapeutics

Zenodo (CERN European Organization for Nuclear Research)
Menopause: Health Impacts and Treatments
article

Alpha-Fold 3: Revolutionizing Drug Design, Protein Stability, Allostery, and Ai-Driven Therapeutics

article en

Abstract

AlphaFold, an AI-driven protein structure prediction system developed by DeepMind, has revolutionized structural biology by achieving remarkable accuracy in protein modeling. By leveraging deep learning techniques, AlphaFold provides high-resolution three-dimensional protein structures, surpassing traditional experimental methods in speed and efficiency. Its applications span drug discovery, cancer research, genomics, and bioengineering, aiding in mutation impact analysis, molecular simulations, and personalized medicine. Despite its success, AlphaFold faces challenges in modeling intrinsically disordered proteins, predicting allosteric mechanisms, and simulating protein dynamics. Future advancements in AI-driven structural biology, molecular modeling, and open-source collaboration will further expand its impact in biomedical research and therapeutic innovations. This study explores the methodologies, applications, and future prospects of AlphaFold, highlighting its transformative role in computational biology.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 42%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Alpha-Fold 3: Revolutionizing Drug Design, Protein Stability, Allostery, and Ai-Driven Therapeutics · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS